Rituximab for the Treatment of Severe Ocular Manifestations of Behcet's Disease

Clinical trial NCT00664599 · COMPLETED

Trial details

NCT number: NCT00664599
Sponsor: Tehran University of Medical Sciences
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Behcet's Syndrome

Start date: 2006-04-01
Primary completion: 2008-01-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.